Corporate Earnings

Revenue reached $1.12 billion, an increase of $67 million, or 6%, from $1.05 billion in the third quarter of 2025.

Revenue was $714.5 million, up from $592.8 million, a rise of 20.5% on a calculated basis.Operating Incomewas $115.3 million versus $97.1 million, andNet Incomewas $81.9 million, or $1.62 per diluted share, compared with $62.7 million, or $1.28.

North America comparable sales grew 7.9%, with transactions up 2.7% and ticket up 5.0%. International comparable sales rose 0.9%, as a 3.7% increase in ticket was partly offset by a 2.8% decline in comparable transactions.

Total revenue was $322.4 million, up $1.5 million from $320.9 million. OTT revenue rose to $226.6 million from $222.8 million on subscription price increases, while linear and other revenue slipped to $95.8 million from $98.1 million as traditional linear households kept declining. International ancillary …

Operating income reached $20.91 billion, compared with $3.89 billion a year earlier. The company said both figures include a gain on digital assets of the same size, $20.91 billion and $3.89 billion respectively, so the software operations added nothing to the headline figure on …

Net sales were $147.2 million, a decrease of $5.2 million, or 3%, from $152.4 million. Pricing added $1.0 million, which only partly offset a $6.2 million impact from lower customer production volumes.

MedSurg and Neurotechnology sales were $3.7 billion, up 9.2%, with organic growth of 9.1%. Orthopaedics sales were $2.9 billion, up 5.7% as reported and 5.9% in constant currency.